Dr. Anders is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2 Seeley Mudd, 10 Bryan Searle Drive
Durham, NC 27710Phone+1 919-684-8111- Is this information wrong?
Summary
- Dr. Carey K. Anders is the Medical Director of the Duke Brain and Spine Metastases Program and a member of the Neuro-Oncology (primary) and Breast Cancer (secondary) Programs within the Duke Cancer Institute. Dr. Anders is a leading expert in the clinical care of patients with breast cancer of all stages, with a research focus in breast cancer that spreads to the central nervous system (CNS).
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
- Duke University HospitalResidency, Internal Medicine, 2002 - 2005
- Brody School of Medicine at East Carolina UniversityClass of 2002
Certifications & Licensure
- NC State Medical License 2002 - 2025
Clinical Trials
- Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib Start of enrollment: 2023 Mar 23
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer.Tira J Tan, Sarah Sammons, Young-Hyuck Im, Lilin She, Kelly Mundy, Robert Bigelow, Tiffany A Traina, Carey Anders, Joe Yeong, Ezequiel Renzulli, Sung-Bae Kim, Rebecca ...> ;Clinical Cancer Research. 2024 Apr 1
- Triple Negative Breast Cancer and Brain Metastases.Rani Bansal, Amanda E D Van Swearingen, Carey K Anders> ;Clinical Breast Cancer. 2023 Dec 1
- 2 citationsEfficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.Benjamin G Vincent, Danielle M File, Karen P McKinnon, Dominic T Moore, Jeffrey A Frelinger, Edward J Collins, Joseph G Ibrahim, Lisa Bixby, Shannon Reisdorf, Sonia J ...> ;Journal of Immunology. 2023 Jul 15
- Join now to see all
Press Mentions
- Could MRI Help Detect Brain Metastases from Breast Cancer?October 10th, 2022
- White Glove Service for Brain and Spine Metastasis PatientsAugust 25th, 2022
- For Small Brain Metastases, Stereotactic Radiosurgery Alone Was Found to Lead to Less Cognitive Deterioration Than Whole Brain Radiotherapy plus the Stereotactic RadiosurgerySeptember 8th, 2016
Hospital Affiliations
- Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: